This inventor holds 1 USPTO granted patent. Top assignee: Kingdomway Biotech. (Jiangsu) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jinchao Zhong: Innovator in Biotech
Introduction
Jinchao Zhong is a prominent inventor based in Fujian, China. He has made significant contributions to the field of biotechnology, particularly through his innovative patents. His work focuses on the development of novel methods and applications that have the potential to impact various industries.
Latest Patents
Jinchao Zhong holds a patent for a "Carbonyl reductase mutant, preparation method and use thereof, and preparation method of ethyl (R)-6-hydroxy-8-chlorooctanoate." This patent showcases his expertise in enzymatic processes and their applications in biochemistry. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge and practical applications.
Career Highlights
Zhong is currently employed at Kingdomway Biotech (Jiangsu) Co., Ltd., where he continues to push the boundaries of research and development. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.
Collaborations
Throughout his career, Jinchao Zhong has worked alongside notable colleagues, including Jun Zhu and Fei Xu. These collaborations have fostered a dynamic environment for innovation and have led to the development of groundbreaking technologies.
Conclusion
Jinchao Zhong is a dedicated inventor whose work in biotechnology exemplifies the spirit of innovation. His contributions, particularly in the area of carbonyl reductase mutants, highlight the importance of research and collaboration in advancing scientific understanding.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile